The Safety of Micro-Implants for the Brain

Abdel-Hameed Dabbour; Sheryl Tan; Sang Ho Kim; Sarah-Jane Guild; Peter Heppner; Daniel McCormick; Bryon E Wright; Dixon Leung; Robert Gallichan; David Budgett; Simon C Malpas

doi:10.3389/fnins.2021.796203

The Safety of Micro-Implants for the Brain

Front Neurosci. 2021 Dec 9:15:796203. doi: 10.3389/fnins.2021.796203. eCollection 2021.

Affiliations

¹ Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
² Centre for Brain Research, Department of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.
³ Auckland Bioengineering Institute, Department of Physiology, University of Auckland, Auckland, New Zealand.
⁴ Auckland District Health Board, Auckland, New Zealand.

Abstract

Technological advancements in electronics and micromachining now allow the development of discrete wireless brain implantable micro-devices. Applications of such devices include stimulation or sensing and could enable direct placement near regions of interest within the brain without the need for electrode leads or separate battery compartments that are at increased risk of breakage and infection. Clinical use of leadless brain implants is accompanied by novel risks, such as migration of the implant. Additionally, the encapsulation material of the implants plays an important role in mitigating unwanted tissue reactions. These risks have the potential to cause harm or reduce the service of life of the implant. In the present study, we have assessed post-implantation tissue reaction and migration of borosilicate glass-encapsulated micro-implants within the cortex of the brain. Twenty borosilicate glass-encapsulated devices (2 × 3.5 × 20 mm) were implanted into the parenchyma of 10 sheep for 6 months. Radiographs were taken directly post-surgery and at 3 and 6 months. Subsequently, sheep were euthanized, and GFAP and IBA-1 histological analysis was performed. The migration of the implants was tracked by reference to two stainless steel screws placed in the skull. We found no significant difference in fluoroscopy intensity of GFAP and a small difference in IBA-1 between implanted tissue and control. There was no glial scar formation found at the site of the implant's track wall. Furthermore, we observed movement of up to 4.6 mm in a subset of implants in the first 3 months of implantation and no movement in any implant during the 3-6-month period of implantation. Subsequent histological analysis revealed no evidence of a migration track or tissue damage. We conclude that the implantation of this discrete micro-implant within the brain does not present additional risk due to migration.

Keywords: brain implant; implant migration; micro-implant; micro-implant GFAP; micro-implant IBA-1; micro-implant safety; microdevice.